EMPOWER-Lung 3 Part 1
EMPOWER-Lung 3 Part 1: Patient-Reported Outcomes With First-line Cemiplimab + Chemotherapy + Ipilimumab in Advanced NSCLC

Released: May 13, 2024

Expiration: May 12, 2025

Activity

Progress
1
Course Completed